<DOC>
	<DOCNO>NCT02017119</DOCNO>
	<brief_summary>Hepatic encephalopathy ( HE ) important complication liver cirrhosis . Lactulose first line treatment HE , adherence treatment relatively low , due side effect diarrhea , distention , etc .</brief_summary>
	<brief_title>Comparison Between Lactulose Lactulose-Paraffin Cirrhotic Patients</brief_title>
	<detailed_description>Lactulose first line treatment HE , adherence treatment relatively low due side effect . Lactulose-paraffin recently available market use treatment HE , possibly few side effect . The aim study compare adherence treatment lactulose lactulose-paraffin .</detailed_description>
	<mesh_term>Brain Diseases</mesh_term>
	<mesh_term>Hepatic Encephalopathy</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<criteria>Liver cirrhosis History event hepatic encephalopathy . Ambulatory patient Alcoholism active ingest alcohol last 6 month Labour turnover Pregnancy Personal history surgery last 4 week Spontaneous bacterial Peritonitis Use neuropsychiatric drug Neuropsychiatric disorder ( Schizophrenia , bipolar disorder , major depression , dementia Attentiondeficit hyperactivity disorder ) Thyroid disorder without replacement therapy Renal failure Hepatic renal transplant Personal history hepatocellular carcinoma Placement transjugular intrahepatic portosystemic shunt Use probiotic last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>